Insulet Stock Probability Of Bankruptcy
PODD Stock | USD 170.78 1.60 0.95% |
Insulet | Probability Of Bankruptcy |
Insulet Probability Of Bankruptcy Analysis
Insulet's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 500K | 9.8M | 28.9M | 30.3M | Tax Provision | 3.7M | 5.2M | 9.1M | 9.6M |
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Insulet Probability Of Bankruptcy | Less than 3% |
Most of Insulet's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Insulet is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Insulet probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Insulet odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Insulet financial health.
Is Insulet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.043 | Earnings Share 2.94 | Revenue Per Share 24.331 | Quarterly Revenue Growth 0.379 | Return On Assets 0.0609 |
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Insulet Probability Of Bankruptcy Driver Correlations
Understanding the fundamental principles of building solid financial models for Insulet is extremely important. It helps to project a fair market value of Insulet Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Insulet's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Insulet's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Insulet's interrelated accounts and indicators.
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition |
Based on the latest financial disclosure, Insulet has a Probability Of Bankruptcy of 3.0%. This is 93.07% lower than that of the Health Care Equipment & Supplies sector and 92.71% lower than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 92.47% higher than that of the company.
Insulet Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Insulet's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Insulet could also be used in its relative valuation, which is a method of valuing Insulet by comparing valuation metrics of similar companies.Insulet is currently under evaluation in probability of bankruptcy category among related companies.
Insulet Main Bankruptcy Drivers
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Return On Assets | 0.0101 | 0.003631 | 0.0082 | 0.002043 | 0.0797 | 0.0837 | |
Asset Turnover | 0.65 | 0.48 | 0.54 | 0.58 | 0.66 | 0.46 | |
Gross Profit Margin | 0.66 | 0.65 | 0.64 | 0.68 | 0.62 | 0.72 | |
Net Debt | 511.8M | 96.1M | 457.2M | 727.1M | 798.1M | 838.0M | |
Total Current Liabilities | 157.7M | 207.8M | 228.8M | 364.7M | 451.2M | 473.8M | |
Non Current Liabilities Total | 909.3M | 1.1B | 1.3B | 1.4B | 1.4B | 1.5B | |
Total Assets | 1.1B | 1.9B | 2.0B | 2.3B | 2.6B | 2.7B | |
Total Current Assets | 591M | 1.2B | 1.3B | 1.3B | 1.6B | 1.6B | |
Total Cash From Operating Activities | 98.4M | 84M | (68.1M) | 119M | 145.4M | 152.7M |
Insulet Fundamentals
Return On Equity | 0.34 | ||||
Return On Asset | 0.0609 | ||||
Profit Margin | 0.12 % | ||||
Operating Margin | 0.26 % | ||||
Current Valuation | 12.54 B | ||||
Shares Outstanding | 69.93 M | ||||
Shares Owned By Insiders | 0.46 % | ||||
Shares Owned By Institutions | 99.54 % | ||||
Number Of Shares Shorted | 2.8 M | ||||
Price To Book | 16.15 X | ||||
Price To Sales | 6.97 X | ||||
Revenue | 1.7 B | ||||
Gross Profit | 805.6 M | ||||
EBITDA | 220 M | ||||
Net Income | 206.3 M | ||||
Cash And Equivalents | 708.6 M | ||||
Cash Per Share | 10.21 X | ||||
Total Debt | 1.45 B | ||||
Debt To Equity | 3.34 % | ||||
Current Ratio | 4.69 X | ||||
Book Value Per Share | 10.48 X | ||||
Cash Flow From Operations | 145.4 M | ||||
Short Ratio | 2.66 X | ||||
Earnings Per Share | 2.94 X | ||||
Price To Earnings To Growth | 3.04 X | ||||
Target Price | 237.57 | ||||
Number Of Employees | 3 K | ||||
Beta | 0.98 | ||||
Market Capitalization | 11.83 B | ||||
Total Asset | 2.59 B | ||||
Retained Earnings | (378 M) | ||||
Working Capital | 1.13 B | ||||
Current Asset | 190.76 M | ||||
Current Liabilities | 65.16 M | ||||
Z Score | 6.16 | ||||
Net Asset | 2.59 B |
About Insulet Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Insulet's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Insulet using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Insulet based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. Insulet Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2300 people.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Insulet using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Insulet Piotroski F Score and Insulet Altman Z Score analysis. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.Note that the Insulet information on this page should be used as a complementary analysis to other Insulet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Insulet Stock analysis
When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Insulet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.043 | Earnings Share 2.94 | Revenue Per Share 24.331 | Quarterly Revenue Growth 0.379 | Return On Assets 0.0609 |
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.